Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000011539 | SCV001722805 | benign | Polyagglutinable erythrocyte syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000011539 | SCV002796163 | likely benign | Polyagglutinable erythrocyte syndrome | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003974818 | SCV004799274 | benign | C1GALT1C1-related disorder | 2019-10-22 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV004713169 | SCV005278004 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000011539 | SCV000031771 | pathogenic | Polyagglutinable erythrocyte syndrome | 2005-10-27 | no assertion criteria provided | literature only |